{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-004491","form_type":"8-K","ticker":null,"cik":"0001783032","company_name":"Elevation Oncology, Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.699053+00:00","generated_at":"2026-05-23T21:16:30.685209+00:00","sec_items":["2.04"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Elevation Oncology to voluntarily prepay $32.2M term loan with K2HV","bullets":["Principal of $30.0M plus prepayment fee of $300K, final payment $1.935M, and accrued interest.","Expected prepayment date on or about May 3, 2025.","Loan agreement originally signed July 27, 2022, amended March 1, 2024.","Company delivered written notice of election to prepay all outstanding term loan."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-004491","json":"https://secwatch.observer/filing/0001558370-25-004491.json","markdown":"https://secwatch.observer/filing/0001558370-25-004491.md","text":"https://secwatch.observer/filing/0001558370-25-004491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783032/000155837025004491/0001558370-25-004491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783032/000155837025004491/elev-20250403x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T21:16:30.685209+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c2b3089269835e987a3922862e3dd6684d5efdd4","claim":"Elevation Oncology, Inc. faced acceleration on term loan of $30.0 million with K2 HealthVentures LLC.","evidence_excerpt":"Ankura Trust Company, LLC, as collateral agent. ​ Pursuant to the Loan Agreement, the Lenders provided a term loan to the Company in the aggregate original principal amount of $30.0 million (the “Term Loan”). Under the Loan Agreement, the Company has the option to prepay all, but not less than all, of the Term Loan, provided that the Company pays on the date of such","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1783032/000155837025004491/0001558370-25-004491-index.htm","confidence":0.85,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$30.0 million"},{"label":"Counterparty","value":"K2 HealthVentures LLC"},{"label":"Event","value":"acceleration"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}